Asset Details
Do you wish to reserve the book?
Immune Thrombocytopenia
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Immune Thrombocytopenia
Do you wish to request the book?
Immune Thrombocytopenia
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Immune Thrombocytopenia
2019
Overview
Immune thrombocytopenia in patients who present with serious bleeding is treated with platelet transfusions, glucocorticoids, and intravenous immune globulin. In patients without serious bleeding, treatment decisions are guided by the platelet count and other factors. Commonly used agents include glucocorticoids, thrombopoietin-receptor agonists, and rituximab.
Publisher
Massachusetts Medical Society
Subject
/ Bleeding
/ Blood Platelets - immunology
/ Female
/ Glucocorticoids - therapeutic use
/ Humans
/ Idiopathic thrombocytopenic purpura
/ Immunoglobulins, Intravenous - therapeutic use
/ Patients
/ Practice Guidelines as Topic
/ Purpura, Thrombocytopenic, Idiopathic - diagnosis
/ Purpura, Thrombocytopenic, Idiopathic - physiopathology
/ Purpura, Thrombocytopenic, Idiopathic - therapy
